ADGRL3 and urinary bladder carcinoma: We had originally identified LPHN3 as a potential AR target from our DNA microarray analysis in a control AR-positive bladder cancer UMUC3 cell line versus an AR-knockdown UMUC3 subline stably expressing AR-shRNA [23,24].